Pierre Lorenzo's most recent trade in Tempest Therapeutics Inc was a trade of 8,477 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 21, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tempest Therapeutics Inc | Pierre Lorenzo | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 8,477 | 8,477 | - | - | Stock Option (Right to Buy) | |
| Tempest Therapeutics Inc | Pierre Lorenzo | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 6,500 | 6,500 | - | - | Stock Option (Right to Buy) | |
| Tempest Therapeutics Inc | Pierre Lorenzo | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 48,535 | 48,535 | - | - | Stock Option (Right to Buy) | |
| Tempest Therapeutics Inc | Pierre Lorenzo | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 4,830 | 4,830 | - | - | Stock Option (Right to Buy) | |
| Tempest Therapeutics Inc | Pierre Lorenzo | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 1,234 | 1,234 | - | - | Stock Option (Right to Buy) | |
| Tempest Therapeutics Inc | Pierre Lorenzo | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 53 | 53 | - | - | Common Stock |